Skip to main content

Table 4 Multivariate analysis for prediction of non-invasive NSCLC among clinical stage IA patients

From: Significant correlation between urinary N1, N12-diacetylspermine and tumor invasiveness in patients with clinical stage IA non-small cell lung cancer

Variables

Risk factors

Risk ratio for invasive tumor

95% CI

p-value*

Tumor size (cm)

>2.0

2.871

1.347-6.119

0.006

Urine DiAcSpm level (nmol/g creatinine)

high

3.374

2.736-7.361

0.002

Serum CEA (mg/dL)

≥5.0

2.316

0.841-6.377

0.104

TDR

 < 0.75

6.103

1.962-18.98

<0.001

  1. *Logistic regression analysis, CI = confidence interval, DiAcSpm = diacetylspermine, CEA = serum carcinoembryonic antigen level, TDR = tumor disappearance rate.